Healthcare · Pharmaceutical expenditure
Kazakhstan's pharmaceutical expenditure amounts to 1.60 % GDP of GDP in 2026 — a figure reflecting the country's growing dependence on imported drugs. The bulk of spending goes on expensive medications for cardiovascular and oncological diseases, which dominate the mortality structure. Domestic production covers only about 20% of needs, concentrated on generics in Shymkent and Almaty. The country ranks 48th out of 197 countries on this indicator.
Data for 2026 · unit: % GDP
Position
#48 / 197
Kazakhstan world ranking
Country position on the scale from last to first place for this indicator.
KZ
#48
#197#1
Trend
Change over time
Change in indicator over the available period.
0.80
1990
0.90
2000
1.20
2010
1.50
2020
1.60
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Kazakhstan stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Kazakhstan — how much?
Based on 2026 data — 1.60 % GDP. This is rank #48 out of 197 countries.
What is Kazakhstan's rank by Pharmaceutical expenditure?
Kazakhstan ranks #48 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Kazakhstan?
Over the available period the indicator changed from 0.80 to 1.60 % GDP.